Auransa Inc.

Auransa is fundamentally changing the way drugs are discovered for conditions like cancer and Alzheimer’s disease. We address the entire spectrum of drug development, from analyzing molecular data to identifying compounds for clinical development.

Auransa’s sophisticated, proprietary platform and diagnostic technology generate insights from molecular data for a deep understanding of disease biology and patient subtypes. This information drives discovery of compounds designed to most effectively address significant unmet medical needs.